Finance

Lists
ZBIO:NASDAQ
Zenas Biopharma Inc
US$ २४.६८
-१.९१%
(-०.४८) 1D
अक्टोबर १४, १५:१३:५१ GMT-४  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for ZBIO...
Open
US$ २४.८२
High
US$ २६.४९
Low
US$ २४.३९
Mkt. cap
१.६१ अरब
Avg. vol.
६.८३ लाख
Volume
१.७७ लाख
52-wk high
US$ ४४.५४
52-wk low
US$ १३.५०
EPS
-US$ ८.९७
Shares outstanding
६.५२ करोड
No. of employees
१६७
Open
US$ २४.८२
High
US$ २६.४९
Low
US$ २४.३९
Mkt. cap
१.६१ अरब
Avg. vol.
६.८३ लाख
Volume
१.७७ लाख
52-wk high
US$ ४४.५४
52-wk low
US$ १३.५०
EPS
-US$ ८.९७
Shares outstanding
६.५२ करोड
No. of employees
१६७
News stories
From web sources and news partners
Investing.com
Investing.com
·
१ दिन पहिले
H.C. Wainwright reiterates Zenas Biopharma stock rating at buy
TipRanks
TipRanks
·
१ दिन पहिले
Zenas BioPharma Highlights New Phase 3 Obexelimab Data
About Zenas Biopharma Inc
CEO-
Employees१६७
Founded२०१९
HeadquartersWaltham, म्यासेचुसेट्स, संयुक्त राज्य अमेरिका
Sector-
Analyst ratings
Based on 5 analysts giving stock ratings to ZBIO in the past 3 months
Strong buy
Buy
4
Hold
1
Sell
0
12-month forecast
Based on 5 Wall Street analysts offering 12 month price targets for ZBIO in the last 3 months.
Highest
Current US$ २४.६८
US$ ५५.०० (+१२२.८५%)
Average
US$ ४४.८० (+८१.५२%)
Lowest
US$ ३२.०० (+२९.६६%)
Analyst
Recommendation
Action
Price target
Projected
Date
Unknown Analyst
Wedbush
Buy
Maintained
US$ ४५.००
+८२.३%
10/13/2026
Matthew Caufield
H.C. Wainwright
Buy
Reiterated
US$ ४४.००
+७८.३%
10/13/2026
Yigal Nochomovitz
Citi
Buy
Maintained
US$ ४८.००
+९४.५%
10/12/2026
Martin Fan
Wedbush
Buy
Maintained
US$ ४५.००
+८२.३%
09/30/2026
Judah Frommer
Morgan Stanley
Hold
Maintained
US$ ३२.००
+२९.७%
08/17/2026
David Nierengarten
Wedbush
Buy
Maintained
US$ ४५.००
+८२.३%
08/14/2026
Yatin Suneja
Guggenheim
Buy
Reiterated
US$ ५५.००
+१२२.९%
08/13/2026
Patrick Trucchio
H.C. Wainwright
Buy
Reiterated
US$ ४४.००
+७८.३%
06/08/2026
Cory Kasimov
Evercore ISI
Buy
Maintained
US$ ५५.००
+१२२.९%
03/17/2026
Last report
२०२६ अगस्ट १३
Fiscal period
Q2 2026
-US$ १.७७ / -US$ ०.७५
-१३४.४४%miss
Revenue / Est. (USD)
१०.०० लाख / १.५० करोड
-९३.३३%miss
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
२०२५ सेप्टेम्बर
२०२५ डिसेम्बर
२०२६ मार्च
२०२६ जुन
Revenue
-
-
-
१०.०० लाख
Cost of goods sold
३.४४ करोड
५.५७ करोड
६.०४ करोड
६.२९ करोड
Cost of revenue
३.४४ करोड
५.५७ करोड
६.०४ करोड
६.२९ करोड
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
१.३२ करोड
१.५६ करोड
१.६९ करोड
१.५७ करोड
Operating expense
१.३२ करोड
१.५६ करोड
१.६९ करोड
१.५७ करोड
Total operating expenses
४.७६ करोड
७.१३ करोड
७.७४ करोड
७.८७ करोड
Operating income
-४.७६ करोड
-७.१३ करोड
-७.७४ करोड
-७.७७ करोड
Other non operating income
१०.८१ लाख
-७४.७६ लाख
-२४.०० हजार
१६.०० हजार
EBT including unusual items
-५.१५ करोड
-२४.०३ करोड
-८.१० करोड
-११.१३ करोड
EBT excluding unusual items
-४.६५ करोड
-७.३७ करोड
-८.१० करोड
-८.१३ करोड
Income tax expense
-
१.०६ लाख
-
१.१४ लाख
Effective tax rate
-
-०.०४%
-
-०.१०%
Other operating expenses
-
-
-
-
Net income
-५.१५ करोड
-२४.०४ करोड
-८.१० करोड
-११.१५ करोड
Net profit margin
-
-
-
-११,१४५.६०%
Earnings per share
-१.२२
-१.३९
-१.४६
-१.७७
Interest and investment income
-
१.२२ करोड
३०.१८ लाख
६६.०३ लाख
Interest expense
-
-७३.२७ लाख
-६६.३१ लाख
-१.०३ करोड
Net interest expenses
-
४८.२४ लाख
-३६.१३ लाख
-३६.९९ लाख
Depreciation and amortization charges
-
-
-
-
EBITDA
-४.७६ करोड
-७.१३ करोड
-७.७३ करोड
-७.७७ करोड
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
Google एपहरू